Aripiprazole Tablet
Product Images NDC 50090-6403

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50090-6403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Aripiprazole Fig1)

A pharmacokinetic chart illustrating the effect of various drugs on Aripiprazole's fold change with 90% confidence intervals. It compares CYP3A4 inhibitors, CYP2D6 inhibitors, CYP3A4 inducers, gastric acid blockers, and other drugs on Aripiprazole's AUC and Cmax, showing changes relative to a reference without interacting drugs.*

FDA Label Image

Figure (Aripiprazole Fig2)

A pharmacokinetic chart titled 'Effect of Other Drugs on Aripiprazole' showing the fold change and 90% confidence interval for dehydro-Aripiprazole with various interacting drugs. The chart compares changes in AUC and Cmax relative to a reference without interacting drugs, listing inhibitors, inducers, gastric acid blockers, and other drugs like ketoconazole, quinidine, carbamazepine, famotidine, valproate, and lorazepam.*

FDA Label Image

Figure (Aripiprazole Fig3)

A forest plot illustrating the effect of Aripiprazole on the pharmacokinetics of various drugs, showing fold change with 90% confidence intervals. The graph compares drugs metabolized by CYP2D6, CYP2C9/2C19, UGT1A4, and other mechanisms, plotting change relative to a reference without interacting drug on the x-axis.*

FDA Label Image

Figure (Aripiprazole Fig4)

A chart depicting fold changes and 90% confidence intervals in pharmacokinetic parameters (AUC and Cmax) of aripiprazole across various special populations, including CYP2D6 metabolizer status, gender, age groups, hepatic impairment severity, and severe renal impairment.*

FDA Label Image

Figure (Aripiprazole Fig5)

A chart depicting the fold change and 90% confidence intervals in pharmacokinetic parameters AUC and Cmax for Aripiprazole. The graph compares these parameters relative to reference values across factors including CYP2D6 metabolizer status, gender, age groups, hepatic impairment severity, and severe renal impairment.*

FDA Label Image

Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)

A Kaplan-Meier curve depicting the cumulative proportion of patients with relapse over 182 days from randomization in a schizophrenia study. The graph compares relapse rates between Aripiprazole and placebo groups, showing corresponding numbers of subjects at risk over time on the x-axis and relapse proportion on the y-axis.*

FDA Label Image

Figure 9: Least Square Means Of Change From Baseline In Ygtss Tts By Week (tourette’s Disorder Study 1) (Aripiprazole Fig7)

A line graph depicting the change in YGTSS total tic score from baseline over 8 weeks of treatment. The graph compares three groups: Aripiprazole low dose, Aripiprazole high dose, and placebo. The y-axis shows the least-squares mean change in YGTSS total tic score, and the x-axis shows weeks of treatment. Both Aripiprazole doses show a greater decrease in tic score over time compared to placebo.*

FDA Label Image

Aripiprazole Structure (Aripiprazole Str)

Chemical structure of Aripiprazole showing the arrangement of its chlorinated aromatic ring, piperazine ring, and quinolinone moieties connected through an ether linkage.*

FDA Label Image

Label Image (Lbl500906403)

Aripiprazole 20 mg tablet label from A-S Medication Solutions. The label includes product name and strength, storage instructions (77 to 87 degrees F), package quantity of 30 tablets, and a barcode with dosage pack insert information. Distributed by A-S Medication Solutions in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.